Aaron John Spittler

Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial

Anish Thomas, Arun Rajan, Arlene Berman et al. · The Lancet Oncology · 2015 · 299 citations · Full text

Medicine, Oncology, Pharmacology +8

Phase 1 Pharmacogenetic and Pharmacodynamic Study of Sorafenib With Concurrent Radiation Therapy and Gemcitabine in Locally Advanced Unresectable Pancreatic Cancer

E. Gabriela Chiorean, Bryan P. Schneider, Fatih Akisik et al. · International Journal of Radiation Oncology*Biology*Physics · 2014 · 31 citations

Medicine, Oncology, Pharmacology +17

Ocular metastasis of colorectal cancer

Muhammad Rizwan Khawaja, John Minturn, Aaron John Spittler et al. · Hematology/Oncology and Stem Cell Therapy · 2015 · 29 citations · Full text

Medicine, Oncology, Ophthalmology +17

Phase II trial of single agent amrubicin in patients with previously treated advanced thymic malignancies

Jessica A. Hellyer, Matthew A. Gubens, Kristen Cunanan et al. · Lung Cancer · 2019 · 21 citations

Medicine, Oncology, Pharmacology +6

A phase II study of buparlisib in relapsed or refractory thymomas

Mohammad Issam Abu Zaid, Milan Radovich, Sandra K. Althouse et al. · Frontiers in Oncology · 2022 · 15 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +13